Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation. (Q43197957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Pei De-An

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Li Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xu Zhi-Yun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Huang Jin-Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Xu Zheng-Ming

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Wang Min

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yao Qiang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Huang Shi-Eng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

23-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

16 January 2020

cites work

1 reference

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

21 January 2018

1 reference

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

21 January 2018

1 reference

Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

Mineralocorticoid selectivity: molecular and cellular aspects

21 January 2018

1 reference

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

21 January 2018

1 reference

11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action

21 January 2018

1 reference

Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure

21 January 2018

1 reference

Atrial fibrosis and the mechanisms of atrial fibrillation

21 January 2018

1 reference

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

21 January 2018

1 reference

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

The new biology of aldosterone

21 January 2018

1 reference

The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat.

21 January 2018

1 reference

Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells

21 January 2018

1 reference

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

21 January 2018

1 reference

12 December 2020

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

12 December 2020

Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure

1 reference

12 December 2020

Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation

1 reference

12 December 2020

Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.20689

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

release_hjgd2qgw45d53ei3iepxwqb664

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hjgd2qgw45d53ei3iepxwqb664

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20063294%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

20063294

1 reference